Latest news with #cardiacSurgery
Yahoo
23-06-2025
- Health
- Yahoo
NEL Animal Cardiovascular Center Achieves World's First Surgical Correction of Complex VSD in Canine Patient
ANYANG, South Korea, June 23, 2025--(BUSINESS WIRE)--NEL Animal Cardiovascular Center, a private 24-hour animal hospital in South Korea, said that its cardiac surgery team has successfully performed the world's first surgical correction of a complex ventricular septal defect (VSD) in a canine patient. This veterinary milestone is highly significant, as it marks the first such case not only in Korea but also globally, with no previous reports of successful surgical treatment for complex VSDs. The patient was diagnosed with a unique form of VSD—a single, continuous defect extending from the perimembranous to the subarterial region (Perimembranous VSD extending into subarterial region). Given that there had been no prior successful surgical cases even for typical VSDs in veterinary medicine, this breakthrough greatly expands the possibilities for surgical treatment of congenital heart disease in Korea's veterinary cardiac surgery field. Over the past year, NEL's cardiac surgery team has gained experience through more than 50 open-heart surgeries using cardiopulmonary bypass. Based on this expertise, the team developed a thorough surgical plan. During the procedure, the complex VSD involving both membranous and subarterial regions was confirmed. The team performed incisions in the right atrium and pulmonary artery, successfully closing the defect with a bovine pericardial patch. Immediately after surgery, the left-to-right shunt was completely resolved, and the risk of progressive regurgitation due to aortic valve prolapse was eliminated. The patient's cardiac function recovered to near-normal levels, and the long-term prognosis is considered highly favorable. Subarterial VSDs are particularly dangerous due to the risk of aortic valve prolapse and severe regurgitation, making early surgical intervention crucial. The success of this surgery offers new hope for animals with congenital heart defects, demonstrating the potential for a surgical cure. Dr. Tae-Heum Um, Director of NEL Animal Cardiovascular Center, stated, "Although this was a complex defect, thorough discussion and preparation among our medical team led to a successful outcome. We will continue our efforts so that more animals with congenital heart disease can lead healthy and normal lives." NEL Animal Cardiovascular Center is preparing an academic analysis and official report on this case, and sincerely hopes that this achievement contributes to the advancement of veterinary cardiac surgery not only in Korea, but also across Asia. View source version on Contacts NEL Animal Cardiovascular CenterYoon il-yong+82-31-421-7579heart@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Associated Press
23-06-2025
- Health
- Associated Press
NEL Animal Cardiovascular Center Achieves World's First Surgical Correction of Complex VSD in Canine Patient
ANYANG, South Korea--(BUSINESS WIRE)--Jun 22, 2025-- NEL Animal Cardiovascular Center, a private 24-hour animal hospital in South Korea, said that its cardiac surgery team has successfully performed the world's first surgical correction of a complex ventricular septal defect (VSD) in a canine patient. This press release features multimedia. View the full release here: NEL Animal Cardiovascular Center's medical staff performing surgical correction of a complex ventricular septal defect (VSD) in a canine patient (Photo: NEL Animal Cardiovascular Center) This veterinary milestone is highly significant, as it marks the first such case not only in Korea but also globally, with no previous reports of successful surgical treatment for complex VSDs. The patient was diagnosed with a unique form of VSD—a single, continuous defect extending from the perimembranous to the subarterial region (Perimembranous VSD extending into subarterial region). Given that there had been no prior successful surgical cases even for typical VSDs in veterinary medicine, this breakthrough greatly expands the possibilities for surgical treatment of congenital heart disease in Korea's veterinary cardiac surgery field. Over the past year, NEL's cardiac surgery team has gained experience through more than 50 open-heart surgeries using cardiopulmonary bypass. Based on this expertise, the team developed a thorough surgical plan. During the procedure, the complex VSD involving both membranous and subarterial regions was confirmed. The team performed incisions in the right atrium and pulmonary artery, successfully closing the defect with a bovine pericardial patch. Immediately after surgery, the left-to-right shunt was completely resolved, and the risk of progressive regurgitation due to aortic valve prolapse was eliminated. The patient's cardiac function recovered to near-normal levels, and the long-term prognosis is considered highly favorable. Subarterial VSDs are particularly dangerous due to the risk of aortic valve prolapse and severe regurgitation, making early surgical intervention crucial. The success of this surgery offers new hope for animals with congenital heart defects, demonstrating the potential for a surgical cure. Dr. Tae-Heum Um, Director of NEL Animal Cardiovascular Center, stated, 'Although this was a complex defect, thorough discussion and preparation among our medical team led to a successful outcome. We will continue our efforts so that more animals with congenital heart disease can lead healthy and normal lives.' NEL Animal Cardiovascular Center is preparing an academic analysis and official report on this case, and sincerely hopes that this achievement contributes to the advancement of veterinary cardiac surgery not only in Korea, but also across Asia. View source version on CONTACT: NEL Animal Cardiovascular Center Yoon il-yong +82-31-421-7579 [email protected] KEYWORD: ASIA PACIFIC SOUTH KOREA INDUSTRY KEYWORD: CARDIOLOGY VETERINARY BIOTECHNOLOGY PETS SURGERY HEALTH HEALTH TECHNOLOGY CONSUMER SOURCE: NEL Animal Cardiovascular Center Copyright Business Wire 2025. PUB: 06/22/2025 08:00 PM/DISC: 06/22/2025 07:59 PM
Yahoo
23-06-2025
- Health
- Yahoo
NEL Animal Cardiovascular Center Achieves World's First Surgical Correction of Complex VSD in Canine Patient
ANYANG, South Korea, June 23, 2025--(BUSINESS WIRE)--NEL Animal Cardiovascular Center, a private 24-hour animal hospital in South Korea, said that its cardiac surgery team has successfully performed the world's first surgical correction of a complex ventricular septal defect (VSD) in a canine patient. This veterinary milestone is highly significant, as it marks the first such case not only in Korea but also globally, with no previous reports of successful surgical treatment for complex VSDs. The patient was diagnosed with a unique form of VSD—a single, continuous defect extending from the perimembranous to the subarterial region (Perimembranous VSD extending into subarterial region). Given that there had been no prior successful surgical cases even for typical VSDs in veterinary medicine, this breakthrough greatly expands the possibilities for surgical treatment of congenital heart disease in Korea's veterinary cardiac surgery field. Over the past year, NEL's cardiac surgery team has gained experience through more than 50 open-heart surgeries using cardiopulmonary bypass. Based on this expertise, the team developed a thorough surgical plan. During the procedure, the complex VSD involving both membranous and subarterial regions was confirmed. The team performed incisions in the right atrium and pulmonary artery, successfully closing the defect with a bovine pericardial patch. Immediately after surgery, the left-to-right shunt was completely resolved, and the risk of progressive regurgitation due to aortic valve prolapse was eliminated. The patient's cardiac function recovered to near-normal levels, and the long-term prognosis is considered highly favorable. Subarterial VSDs are particularly dangerous due to the risk of aortic valve prolapse and severe regurgitation, making early surgical intervention crucial. The success of this surgery offers new hope for animals with congenital heart defects, demonstrating the potential for a surgical cure. Dr. Tae-Heum Um, Director of NEL Animal Cardiovascular Center, stated, "Although this was a complex defect, thorough discussion and preparation among our medical team led to a successful outcome. We will continue our efforts so that more animals with congenital heart disease can lead healthy and normal lives." NEL Animal Cardiovascular Center is preparing an academic analysis and official report on this case, and sincerely hopes that this achievement contributes to the advancement of veterinary cardiac surgery not only in Korea, but also across Asia. View source version on Contacts NEL Animal Cardiovascular CenterYoon il-yong+82-31-421-7579heart@
RNZ News
18-06-2025
- Health
- RNZ News
Media attention, political pressure credited with solving cardiac surgery waitlist at Waikato Hospital
A doctor works on a patient in a surgery. Photo: UnSplash/ JC Gellidon Media attention and political pressure have been credited with solving the eight-week cardiac surgery waitlist at Waikato Hospital. Cardiac Society of New Zealand chairperson Dr Martin Stiles said the cardiac waiting list peaked last year at 110 patients but had now reduced to only 10. "What that has meant for us is that we are able to get through the patients much more quickly, and the patients are waiting a much shorter time." Stiles - who was a cardiologist at Waikato Hospital but spoke in his role as chairperson - said the situation changed after 71-year-old Norm Davies went public with his story in September 2024. Davies had waited in hospital for more than a month for cardiac surgery and had been told to expect at least another three-week wait. "It was really frustrating at the time, because what we were telling patients was, 'yes you do need an operation but no we can't do it this week, or next week, or even the week after'," Stiles said. Cardiac Society of New Zealand chairperson Dr Martin Stiles. Photo: Supplied: Martin Stiles He said after the RNZ stories, senior management began to focus on the issue and political pressure was put on resolving the situation. "There was visibility at the top of the organisation, where previously there really wasn't." One of the problems was that up to 20 percent of planned operations were being cancelled because it wasn't clear that there would be a recovery bed available. "Now [surgeons] get on with the operation and ICU are committed to finding them a bed, and they are able to just get through the list just much more quickly." Stiles said he was aware of cardiac waitlist issues in other areas of the country, especially in major centres. "What I'd say to Auckland and Wellington is that with engagement from very senior management and perhaps some political pressure from the Ministry, these things can be turned around." However, Stiles said Waikato Hospital continued to generally be under enormous pressure. He hoped that when similar problems are raised, they would get a similar level of priority and solutions from the highest levels. "And I say when, not if." Stiles had concerns about outsourcing surgeries to private hospitals being used as a long-term solution. At present, Waikato cardiac patients are not having their surgeries outsourced because capacity within Waikato Hospital had been created. "When I heard that there were these ideas to have 10-year contracts with private hospitals for surgical waitlists I thought, well that may be useful for the private hospitals but what the public hospitals really need is ability to turn the tap on and turn the tap off in private." He said the risk became that public money would be used to build up private hospitals. "I work in private, it's good, but I would much rather see public money go into a public hospital, I don't want to see public money propping up overseas pension funds who own private hospitals." Sign up for Ngā Pitopito Kōrero , a daily newsletter curated by our editors and delivered straight to your inbox every weekday.
Times of Oman
16-06-2025
- Health
- Times of Oman
National Heart Centre: A leading medical landmark in Oman
Muscat: The National Heart Center at the Royal Hospital stands as a pioneering medical institution in the Sultanate of Oman, continuing to provide cardiology and cardiac surgery services in line with the highest global medical standards. Since its inauguration in 2015, the center has made steady strides toward leadership and excellence in cardiac healthcare, solidifying its status as a reference medical institution at the local, regional, and international levels. Dr. Najib Zahran Al Rawahi, Director of the National Heart Center told Oman News Agency (ONA) that the center was founded on an ambitious vision aimed at achieving leadership in the treatment of cardiovascular diseases and delivering high-quality healthcare to citizens and residents of Oman—from fetal development to adulthood and advanced age. He added that the centre strives to provide a comprehensive range of advanced diagnostic, therapeutic, and surgical services for heart conditions, including arterial, valvular, and congenital diseases. Equipped with the latest medical technologies and devices, the center ensures the highest standard of healthcare. Dr. Al Rawahi emphasized that through these specialized services, the center aims to rank among the leading institutions in the region and the world in cardiac treatment, performing advanced surgical procedures and medical interventions such as catheter-based valve implantation and repair, catheter ablation for arrhythmias, and the dilation of narrowed veins and arteries. He noted that the center is committed to attracting and training distinguished medical professionals to ensure high-quality care, while also keeping its staff updated on the latest techniques and procedures in cardiology and cardiac surgery. The National Heart Center in Oman has seen remarkable developments since its opening in 2015, with expanded and enhanced services to meet the growing needs of patients. This includes an increase in surgical procedures to accommodate rising patient numbers and the adoption of cutting-edge technology across all specialized fields of cardiology and cardiac surgery. The cardiac catheterization department has undergone significant advancements, including the introduction of state-of-the-art specialized catheters on an international scale. The number of daily catheterization sessions has increased from five to six, boosting the department's capacity and reducing waiting times. The center also provides round-the-clock services for critical and complex cases, saving numerous lives. As for the number of surgeries performed since the center's opening, Dr. Al Rawahi pointed out that 9,168 procedures have been conducted, including interventional catheterizations, open-heart surgeries, and minimally invasive surgeries. The success rates range between 93% and 96%, depending on the procedure type, aligning with global standards. Additionally, the center performed 49,846 interventional cardiac catheterizations for adults and 7,823 for children during the same period, with success rates between 97% and 99%, consistent with international benchmarks. On the latest medical technologies in cardiac surgery, Dr. Al Rawahi underscored the center's commitment to adopting cutting-edge advancements, such as minimally invasive heart surgery—one of the newest techniques in the field—which involves small chest incisions to reduce pain and recovery time. The center has introduced modern cardiac catheterization techniques, allowing doctors to diagnose and treat heart conditions without open surgery. These include pediatric electrophysiology catheters, cryoablation catheters for atrial fibrillation, and thermal ablation catheters for arrhythmias. Advanced imaging technologies, such as MRI and CT scans, provide precise visuals of the heart and blood vessels, aiding in accurate diagnosis. The center also employs remote cardiac monitoring systems, enabling close patient observation and early detection of potential issues. Dr. Al Rawahi noted that the center has introduced several innovations in cardiac care, including 'Pulsed Field Ablation,' a groundbreaking global technology for treating atrial fibrillation with high efficacy and minimal complications. Another milestone is the wireless pacemaker 'Aveir,' which regulates heart rhythms without wires, representing a breakthrough in cardiac treatment. The center has also pioneered advanced catheterization techniques, such as transcatheter aortic and pulmonary valve replacements and chronic coronary artery occlusion interventions. A recent landmark achievement was Oman's first successful heart transplant from a brain-dead donor, performed by a multidisciplinary Omani medical team on a patient suffering from heart failure. The five-hour surgery marks a pivotal moment in Oman's healthcare sector, reflecting years of meticulous planning, hard work, and investment in national expertise. Regarding international partnerships, the center collaborates with leading global institutions, including the American Heart Association, which certifies it for advanced cardiac life support training. It also partners with educational institutions like Sultan Qaboos University's College of Medicine and Nursing for clinical training and with Oman Medical Specialty Board to oversee residency programs in adult cardiology, pediatric cardiology, and pediatric intensive care. Looking ahead, the center is committed to expanding and enhancing its services through ambitious future plans, including modernizing operating rooms and catheterization labs, increasing specialized clinics, and promoting scientific research in cardiology. Dr. Al Rawahi highlighted the center's community initiatives, such as the 'Heart of the Nation: One Pulse, One Goal' campaign, which aims to raise awareness about heart disease and early detection across Oman's governorates. Through its advanced infrastructure, skilled workforce, and world-class technologies, the National Heart Center continues to transform its vision into reality, elevating cardiac care in Oman and the region while cementing its status as a regional and international reference institution—setting a benchmark for comprehensive and advanced cardiac healthcare in service to Oman's society. -ONA
